IRCT2016053028182N1已完成3 期
The effectiveness of memantin in the treatment of adult with attention deficit hyperactivity disorder
Kurdistan University of Medical science0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 45 years（—）
- 性别
- All
入选标准
- •receiving DSM-IV-TR diagnostic criteria for ADHD; the age range of 18 to 45 years old; not using any psychiatric drugs at least 2 weeks before the research. Exclusion criteria: having mental retardation; having any psychiatric disorders except Oppositional Defiant disorder; allergic history to Memantine; having serious disorder like heart disease; uncontrolled Seizure disorder; individuals with Systolic blood pressure above 125 mmHg or resting pulse under 60 or having above 115 beats per minute: Pregnant and lactating women
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Assessment the effect of memantine in the treatment of chemotherapy-induced peripheral neuropathychemotherapy-induced peripheral neuropathy in patients with cancer.Idiopathic peripheral autonomic neuropathyG90.0IRCT20160310026998N12Tabriz University of Medical Sciences180
已完成
2 期
Memantine in the treatment of obsessive-compulsive disorderObsessive-compulsive disorderIRCT201106031556N22Tehran University of Medical Sciences40
已完成
2 期
Memantine effect in the treatment of residual symptoms in patients with schizophreniaIRCT2017013032236N2Vice chancellor for research, Mazandaran University of Medical Sciences50
招募中
不适用
Memantine for treatment of Obsessive-Compulsive DisorderObsessive-compulsive disorderIRCT20170123032145N4Iran University of Medical Sciences44
尚未招募
3 期
The effectiveness of the combination of Memantine and Betahistine on insomnia severity, quality of life and severity of symptoms in people with primary tinnitusTinnitusInsomniaIRCT20190427043389N4Zanjan University of Medical Sciences60